Patrick F Smith sold $60k of CERT
PRESIDENT, DRUG DEV SOLUTIONS at Certara, Inc.. 5,409 shares at an average of $11.03, traded Oct 7, 2024, filed Oct 8, 2024.
Score components
- +20RolePresident
- +7Trade size$60k at market
- 0Share of holdings soldSold 9.7% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -2.2%, 3m -0.1%, 6m -19.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-24-024874, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 7, 2024 | SOpen-market sale Common Stock10b5-1 | -5,409 | $11.03 | $60k | 50,091 | Oct 8, 2024 |
Related signals
Other insiders at Certara, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 37Weak | CERTbuy Certara, Inc. | William F Feehery CHIEF EXECUTIVE OFFICER | $200k 24,096 shares | +1% | |
| 29Weak | Certara, Inc. | Leif E Pedersen PRESIDENT, CHIEF COMMERCAL OFF | $559k 51,224 shares | -41% | |
| 29Weak | Certara, Inc. | Leif E Pedersen PRESIDENT, CHIEF COMMERCAL OFF | $578k 51,224 shares | -34% | |
| 26Weak | Certara, Inc. | Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS | $243k 14,427 shares | -22% | |
| 0Weak | Certara, Inc. | Richard M. Traynor SVP AND GENERAL COUNSEL | $54k 3,000 shares | -2% | |
| 10Weak | Certara, Inc. | Richard M. Traynor SVP AND GENERAL COUNSEL | $55k 3,000 shares | -2% | |
| 17Weak | Certara, Inc. | Patrick F Smith PRESIDENT, DRUG DEV SOLUTIONS | $90k 5,000 shares | -8% | |
| 13Weak | Certara, Inc. | Richard M. Traynor SVP AND GENERAL COUNSEL | $108k 6,000 shares | -4% | |
| 5Weak | Certara, Inc. | Richard M. Traynor SVP AND GENERAL COUNSEL | $108k 6,000 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.